LifeStance Health (LFST) Cash from Financing Activities (2020 - 2026)

LifeStance Health (LFST) has 7 years of Cash from Financing Activities data on file, last reported at -$73.0 million in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$73.0 million, down 632.26% year-over-year; the trailing twelve-month figure through Mar 2026 was -$79.0 million (down 351.79% YoY), and the FY2025 annual result was -$16.0 million, down 60.4% from the prior year.
• Cash from Financing Activities retreated to -$73.0 million in Q1 2026 per LFST's latest filing, from -$1.9 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $30.8 million in Q4 2023 and troughed at -$73.0 million in Q1 2026.
• A 5-year average of -$250235.3 and a median of -$1.9 million in 2025 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities soared 183.49% in 2022, then plunged 632.26% in 2026.
• A 5-year view of Cash from Financing Activities shows it stood at $12.7 million in 2022, then jumped by 143.53% to $30.8 million in 2023, then tumbled by 113.16% to -$4.1 million in 2024, then surged by 52.94% to -$1.9 million in 2025, then plunged by 3724.24% to -$73.0 million in 2026.
• Business Quant data shows LFST's Cash from Financing Activities at -$73.0 million in Q1 2026, -$1.9 million in Q4 2025, and -$2.0 million in Q3 2025.